Advertisement

Pharmaceutisch Weekblad

, Volume 5, Issue 4, pp 121–128 | Cite as

Receptors: the materialization of a concept

  • E. J. Ariëns
Review Articles

Abstract

The evolution of the receptor concept over the years, culminating in the materialization thereof is outlined step by step. Attention is paid to molecular pharmacology, affinity and intrinsic activity, partial agonists and partial antagonists, receptor differentiation, receptor kinetics, receptor dynamics, receptor-effector coupling and receptor reserve, localization, quantification and isolation of receptors. Receptor pathology includes ‘inborn errors of receptor function’, involvement of receptors in autoimmune diseases and in malignant diseases. Finally iatrogenic receptor imbalances are discussed.

Keywords

Public Health Internal Medicine Autoimmune Disease Malignant Disease Receptor Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahlquist, R.P. (1948)Am. J. Physiol. 153, 586–600.Google Scholar
  2. Ariëns, E.J. (1964)Molecular Pharmacology, Vol. 1. Academic Press, New York, 119;Ibidem (1979)TIPS 1, 11–15;Ibidem (1981)2, 170–172;Ibidem (1982)Ned. Tijdschr. Geneeskd. 126, 1674–1675;Ibidem (1983)J. Cardiovasc. Pharmacol. 5, S8–S15.Google Scholar
  3. Ariëns, E.J., andW.M. de Groot (1954)Arch. Int. Pharmacodyn. Ther. 99, 193–205.PubMedGoogle Scholar
  4. Ariëns, E.J., andA.M. Simonis (1960)Arch. Int. Pharmacodyn. Ther. 127, 479–496;Ibidem (1983)Biochem. Pharmacol. 32, 1539–1545.PubMedGoogle Scholar
  5. Ariëns, E.J., A.M. Simonis andW.M. de Groot (1955)Arch. Int. Pharmacodyn. Ther. 100, 298–322.PubMedGoogle Scholar
  6. Ariëns, E.J., A.J. Beld, J.F. Rodrigues De Miranda andA.M. Simonis (1979) In:The Receptors. Vol. 1,General principles and procedures (O'Brien, R.D., Ed.). Plenum Press, New York, 33–91.Google Scholar
  7. Arky, R.A. (1982)N. Engl. J. Med. 307, 1445–1447.PubMedGoogle Scholar
  8. Baxter, J.D., andJ.W. Funder (1979)N. Engl. J. Med. 301, 1149–1161.PubMedGoogle Scholar
  9. Beld, A.J., andE.J. Ariëns (1974)Eur. J. Pharmacol. 25, 203–209.CrossRefPubMedGoogle Scholar
  10. Bowman, W.C., andM.J. Rand (1980)Textbook of Pharmacology. Second Edition. Blackwell Scientific Publications, Oxford, 30.20.Google Scholar
  11. Catt, K.J., andM.L. Dufau (1977)Ann. Rev. Physiol. 39, 529–557.CrossRefGoogle Scholar
  12. Catt, K.J., J.P. Harwood, G. Aguilera andM.L. Dufau (1979)Nature 280, 109–116.PubMedGoogle Scholar
  13. Clark, A.J. (1937)Handbuch der experimentellen Pharmakologie. Vol. iv.General Pharmacology. Springer-Verlag, Berlin.Google Scholar
  14. Cummings, D.M., andP.H. Vlasses (1982)Drug Intell. Clin. Pharm. 16, 817–822.PubMedGoogle Scholar
  15. Davies, B., D. Sudera, G. Sagnella, E. Marchesi-Saviotti, CH. Mathias, R. Bannister andP. Sever (1982)J. Clin. Invest. 69, 779–784.PubMedGoogle Scholar
  16. Drachman, D.B. (1979)Fed. Proc. 38, 2606–2615.Google Scholar
  17. Drachman, D.B., R.N. Adams, L.F. Josifek andS.G. Self (1982)N. Engl. J. Med. 307, 769–775.PubMedGoogle Scholar
  18. Editorial (1979)New Scientist 83, 886.Google Scholar
  19. Elewaut, A., M. de Baets andA. Vermeulen (1981)Belg. Tijdschr. Geneeskd. 37, 97–100.Google Scholar
  20. Evered, D., andJ. Whelan (Eds.) (1982)Receptors, Antibodies and Disease. Ciba Found, Symp.90. Pitman, Londen.Google Scholar
  21. Fain, J.N., andJ.A. García-Sáinz (1980)Life Sci. 26, 1183–1194.CrossRefPubMedGoogle Scholar
  22. Fontana, A. (1979)Schweiz. Med. Wochenschr. 109, 353–358.PubMedGoogle Scholar
  23. Gabbay, K.H. (1980)N. Engl. J. Med. 302, 165–167.PubMedGoogle Scholar
  24. Galjaard, H. (1982)Ned. Tijdschr. Geneeskd. 126, 2335–2343.PubMedGoogle Scholar
  25. Gregoriadis, G. (1981)Lancet II, 241–246.CrossRefGoogle Scholar
  26. Griffin, J.E., andJ.D. Wilson (1980)N. Engl. J. Med. 302, 198–209.PubMedGoogle Scholar
  27. Gustafsson, J.Å., Å. Pousette andÖ. Wrange (1980)TIPS 1, 279–281.Google Scholar
  28. Hearn, M.T.W. (1980)TIPS 1, 75–79.Google Scholar
  29. Hollenberg, M.D. (1981)TIPS 2, 320–323.Google Scholar
  30. King, A.Ch., andP. Cuatrecasas (1981)N. Engl. J. Med. 305, 77–88.PubMedGoogle Scholar
  31. Kleinzeller, A. (Ed.) (1983)Current Topics in Membranes and Transport. Vol. 18,Membrane Receptors. Academic Press, New York.Google Scholar
  32. Kknight, J.G. (1982)Lancet II, 1073–1075.CrossRefGoogle Scholar
  33. Lefkowitz, R.J., M.G. Caron, Th. Michel andJ.M. Stadel (1982)Fed. Proc. 41, 2664–2670.PubMedGoogle Scholar
  34. Mackay, D. (1982)TIPS 3, 496–499.Google Scholar
  35. Middlebrook, J.L., andL.D. Kohn (Eds.) (1981)Receptor-mediated binding and internalization of toxins and hormones. Academic Press, New York.Google Scholar
  36. Mmotulsky, H.J., andP.A. Insel (1982)N. Engl. J. Med. 307, 18–29.PubMedGoogle Scholar
  37. Olsen, R.W., T.D. Reisine andH.I. Yamamura (1980)Life Sci. 27, 801–808.CrossRefPubMedGoogle Scholar
  38. Overstreet, D.H., andH.I. Yamamura (1979)Life Sci. 25, 1865–1878.CrossRefPubMedGoogle Scholar
  39. Ppapadimitriou, A., andM. Worcel (1974)Br. J. Pharmacol. 50, 291–297.PubMedGoogle Scholar
  40. Parker, Ch.W. (1981)N. Engl. J. Med. 305, 1212–1213.PubMedGoogle Scholar
  41. Parker, M., andJ. Atkinson (1982)Gen. Pharmac. 13, 79–85.Google Scholar
  42. Raemaekers, J.M.M., L.V.A.M. Beex, A.J.M. Koenders, A.G.H. Smals, G.F.F.M. Pieters, Th.J. Benraad andP.W.C. Kloppenborg (1982)Ned. Tijdschr. Geneeskd. 126, 1493–1498.PubMedGoogle Scholar
  43. Raynaud, J.P., M.M. Bouton andT. Ojasoo (1980)TIPS 1, 324–327.Google Scholar
  44. Rossum, J.M. van (1963)Arch. Int. Pharmacodyn. 143. 299–330.PubMedGoogle Scholar
  45. Roth, G.S. (1979)Fed. Proc. 38, 1910–1914.PubMedGoogle Scholar
  46. Rubenstein, E. (1980)Sci. Am. 242/3, 78–87.Google Scholar
  47. Schlessinger, J. (1980)TIPS 5, 210–214.Google Scholar
  48. Seeman, Ph. (1981)Pharmacol. Rev. 32, 229–292.Google Scholar
  49. Snyder, S.H. (1979)N. Engl. J. Med. 300, 465–472.PubMedGoogle Scholar
  50. Soloff, M.S. (1979)Life Sci. 25, 1453–1460.CrossRefPubMedGoogle Scholar
  51. Stephenson, R.P.A. (1956)Br. J. Pharmacol. 11, 379–393.PubMedGoogle Scholar
  52. Strakosch, CH.R., B.E. Wenzel, V.V. Row andR. Volpé (1982)N. Engl. J. Med. 307, 1499–1505.PubMedGoogle Scholar
  53. Taylor, S.I., G. Grunberger, B. Marcus-Samuels, L.H. Underhill, R.F. Dons, J. Ryan, R.F. Roddam, C.E. Rupe andPh. Gorden (1982)N. Engl. J. Med. 307, 1422–1425.PubMedGoogle Scholar
  54. Tenschert, W., H. Vetter, W. Siegenthaler andW. Vetter (1981)Schweiz. Med. Wochenschr. 111, 174–181.PubMedGoogle Scholar
  55. Werner, S.C., and Ch. VonWestarp (Eds.) (1983)Life Sci. 32, 1–163.Google Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1983

Authors and Affiliations

  • E. J. Ariëns
    • 1
  1. 1.Institute for PharmacologyCatholic University of NijmegenEZ Nijmegen

Personalised recommendations